87 related articles for article (PubMed ID: 2170578)
1. Increased antibody responses to human papillomavirus type 16 L1 protein expressed by recombinant vaccinia virus lacking serine protease inhibitor genes.
Zhou J; Crawford L; McLean L; Sun XY; Stanley M; Almond N; Smith GL
J Gen Virol; 1990 Sep; 71 ( Pt 9)():2185-90. PubMed ID: 2170578
[TBL] [Abstract][Full Text] [Related]
2. The induction of cytotoxic T-lymphocyte precursor cells by recombinant vaccinia virus expressing human papillomavirus type 16 L1.
Zhou JA; McIndoe A; Davies H; Sun XY; Crawford L
Virology; 1991 Mar; 181(1):203-10. PubMed ID: 1847256
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the L1 gene product of human papillomavirus type 16 by expression in a vaccinia virus recombinant.
Browne HM; Churcher MJ; Stanley MA; Smith GL; Minson AC
J Gen Virol; 1988 Jun; 69 ( Pt 6)():1263-73. PubMed ID: 2838573
[TBL] [Abstract][Full Text] [Related]
4. Effect of in vitro mutations in a vaccinia virus early promoter region monitored by herpes simplex virus thymidine kinase expression in recombinant vaccinia virus.
Coupar BE; Boyle DB; Both GW
J Gen Virol; 1987 Sep; 68 ( Pt 9)():2299-309. PubMed ID: 2821171
[TBL] [Abstract][Full Text] [Related]
5. Vaccinia virus encodes a family of genes with homology to serine proteinase inhibitors.
Smith GL; Howard ST; Chan YS
J Gen Virol; 1989 Sep; 70 ( Pt 9)():2333-43. PubMed ID: 2778436
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the virulence of wild-type thymidine kinase (tk)-deficient and tk+ phenotypes of vaccinia virus recombinants after intranasal inoculation of mice.
Taylor G; Stott EJ; Wertz G; Ball A
J Gen Virol; 1991 Jan; 72 ( Pt 1)():125-30. PubMed ID: 1990060
[TBL] [Abstract][Full Text] [Related]
7. Identification and cloning of the fowlpox virus thymidine kinase gene using vaccinia virus.
Boyle DB; Coupar BE
J Gen Virol; 1986 Aug; 67 ( Pt 8)():1591-600. PubMed ID: 3016154
[TBL] [Abstract][Full Text] [Related]
8. [Construction and identification of the replication-deficient recombinant vaccinia virus co-expressing HPV type 16 L1 and L2 proteins].
Han L; Ren J; Liang Y; Tian H; Zhi H; Luo W; Lu Z; Wei L; Ruan L
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Sep; 16(3):256-60. PubMed ID: 12665934
[TBL] [Abstract][Full Text] [Related]
9. Vaccinia virus serpins B13R (SPI-2) and B22R (SPI-1) encode M(r) 38.5 and 40K, intracellular polypeptides that do not affect virus virulence in a murine intranasal model.
Kettle S; Blake NW; Law KM; Smith GL
Virology; 1995 Jan; 206(1):136-47. PubMed ID: 7831769
[TBL] [Abstract][Full Text] [Related]
10. Generation and applications of HPV pseudovirions using vaccinia virus.
Sapp M; Selinka HC
Methods Mol Med; 2005; 119():463-82. PubMed ID: 16350418
[TBL] [Abstract][Full Text] [Related]
11. Vaccinia virus serpins B13R and B22R do not inhibit antigen presentation to class I-restricted cytotoxic T lymphocytes.
Blake NW; Kettle S; Law KM; Gould K; Bastin J; Townsend AR; Smith GL
J Gen Virol; 1995 Sep; 76 ( Pt 9)():2393-8. PubMed ID: 7561783
[TBL] [Abstract][Full Text] [Related]
12. Construction of recombinant vaccinia virus: cloning into the thymidine kinase locus.
Byrd CM; Hruby DE
Methods Mol Biol; 2004; 269():31-40. PubMed ID: 15114005
[TBL] [Abstract][Full Text] [Related]
13. Mapping of the vaccinia virus thymidine kinase gene by marker rescue and by cell-free translation of selected mRNA.
Weir JP; Bajszár G; Moss B
Proc Natl Acad Sci U S A; 1982 Feb; 79(4):1210-4. PubMed ID: 6280173
[TBL] [Abstract][Full Text] [Related]
14. [Molecular biological study of the vaccinia virus genome. IV. The late nonstructural 36K protein of vaccinia virus is vitally important].
Shchelkunov SN; Riazankina OI; Gashnikov PB; Totmenin AB; Chizhikov VE; Malygin EG
Mol Biol (Mosk); 1991; 25(2):396-404. PubMed ID: 1908941
[TBL] [Abstract][Full Text] [Related]
15. Insertion sites for recombinant vaccinia virus construction: effects on expression of a foreign protein.
Coupar BE; Oke PG; Andrew ME
J Gen Virol; 2000 Feb; 81(Pt 2):431-9. PubMed ID: 10644842
[TBL] [Abstract][Full Text] [Related]
16. Comparison of a conserved region in fowlpox virus and vaccinia virus genomes and the translocation of the fowlpox virus thymidine kinase gene.
Binns MM; Tomley FM; Campbell J; Boursnell ME
J Gen Virol; 1988 Jun; 69 ( Pt 6)():1275-83. PubMed ID: 2838574
[TBL] [Abstract][Full Text] [Related]
17. Vaccinia virus DNA ligase is nonessential for virus replication: recovery of plasmids from virus-infected cells.
Kerr SM; Smith GL
Virology; 1991 Feb; 180(2):625-32. PubMed ID: 1989387
[TBL] [Abstract][Full Text] [Related]
18. Systemic cancer therapy with a tumor-selective vaccinia virus mutant lacking thymidine kinase and vaccinia growth factor genes.
McCart JA; Ward JM; Lee J; Hu Y; Alexander HR; Libutti SK; Moss B; Bartlett DL
Cancer Res; 2001 Dec; 61(24):8751-7. PubMed ID: 11751395
[TBL] [Abstract][Full Text] [Related]
19. Generation of thymidine kinase-deficient mutants of infectious laryngotracheitis virus.
Schnitzlein WM; Winans R; Ellsworth S; Tripathy DN
Virology; 1995 Jun; 209(2):304-14. PubMed ID: 7778265
[TBL] [Abstract][Full Text] [Related]
20. Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles.
Zhou J; Sun XY; Stenzel DJ; Frazer IH
Virology; 1991 Nov; 185(1):251-7. PubMed ID: 1656586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]